首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1871771

口服痤疮治疗市场报告：趋势、预测和竞争分析（至2031年）

Oral Acne Medicine Market Report: Trends, Forecast and Competitive Analysis to 2031

出版日期: 2025年11月17日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录图表

全球口服痤疮药物市场预计将成为一个充满发展前景的市场，线上和线下销售管道的双重机会将推动市场成长。预计2025年至2031年间，全球口服痤疮药物市场将以5.1%的复合年增长率成长。成长要素包括：消费者对有效且便捷的痤疮治疗方法的需求不断增长、线上零售的兴起以及全球消费者对护肤和痤疮管理意识提升。

Lucintel预测，在预测期内，非处方药(OTC)的成长率将会更高。
从应用方面来看，预计线上销售将呈现更高的成长率。
从区域来看，预计亚太地区在预测期内将达到最高的成长率。

口服痤疮治疗市场的新趋势

口服痤疮药物市场正经历着重大变革时期，其驱动力包括治疗方法的进步、公众意识的提高以及患者偏好的改变。这些趋势正在改变全球痤疮的治疗和管理方式，影响消费行为以及创新治疗方法的研发。因此，在这些关键趋势的推动下，预计该市场将进一步扩张。

转向个人化治疗：个人化治疗正逐渐成为痤疮治疗的主流趋势，越来越重视根据个体的肤质、遗传因素和痤疮严重程度来定製药物。这种方法可以提高治疗效果并减少副作用，从而提高患者的依从性。基因和微生物组研究的进展使得更有针对性的治疗成为可能，从而开发出更精准有效的口服痤疮治疗药物。
联合疗法的兴起：口服抗生素合併外用药物或口服类视色素等联合疗法正变得越来越受欢迎。这些多管齐下的方法可透过解决导致痤疮的多种因素来提高疗效。这一趋势正在重塑痤疮治疗方案，医生们越来越多地推荐联合疗法，以获得更快、更持久的疗效。
生物製药和新型药物的应用：生物製药和新型药物正逐渐成为中重度痤疮的重要治疗选择。这些药物包括针对免疫系统的生物製药和用于治疗成人痤疮的荷尔蒙疗法。它们可取代传统的抗生素和类视色素药物，副作用更少，疗效更佳。随着更多核准上市，口服痤疮药物市场预计将更加多元化。
成人痤疮治疗日益受到关注：成人痤疮的发生率正在上升，尤其是在女性群体中。这种人口结构的变化推动了口服痤疮治疗药物的研发，这些药物旨在解决成人痤疮的根本原因：荷尔蒙失衡。随着人们对成人痤疮的认识不断提高，专门用于治疗成人痤疮的口服药物市场正在迅速扩张，尤其是在已开发国家。
非处方药需求不断增长：非处方口服痤疮药物的兴起是一个显着的趋势，这主要源于患者对便利且价格合理的治疗方法的偏好。处方笺，例如非处方抗生素和草药补充剂，正变得越来越普遍。这一趋势反映了人们越来越倾向于自我治疗，以及患者对使用非处方药治疗痤疮越来越有信心。

个人化治疗、联合治疗、生物製药、对成人痤疮日益关注以及非处方口服药物的兴起等新兴趋势正在重塑全球口服痤疮药物市场。这些趋势不仅提高了治疗效果，也满足了患者不断变化的需求，最终推动了市场扩张和痤疮治疗的改善。

口服痤疮治疗市场的最新趋势

口服痤疮药物市场正经历快速创新，为满足日益增长的有效治疗方法需求，市场涌现许多重要进展。这些创新涵盖新药核准、市场进入扩大以及旨在改善患者疗效的治疗方案改进。随着越来越多的患者寻求有效且长期的痤疮治疗方案，这些进展正在推动市场成长。

美国食品药物管理局(FDA)核准了多种新型口服痤疮治疗药物，包括新型类视色素和抗生素。这些核准为患者提供了更多选择，尤其对重度痤疮患者而言。新型製剂（例如固定剂量组合药物）的引入，有助于提高治疗依从性和疗效，从而实现更有效的痤疮治疗。
成人痤疮荷尔蒙疗法的兴起：口服荷尔蒙疗法（例如避孕药和抗雄性激素药物）已被广泛认可为治疗成人痤疮的有效方法，尤其是在女性患者中。这些治疗方法直接针对导致成人痤疮的荷尔蒙失衡问题。製药公司正在扩展其产品线，以满足日益增长的成人痤疮治疗方法需求。
生物製药在重度痤疮治疗中的应用：生物製药，例如靶向痤疮相关发炎的单株抗体，正逐渐成为治疗重度痤疮和囊肿型痤疮的极具前景的治疗方法。这些治疗方法尤其适用于对传统疗法（如抗生素和类视色素药物）无反应的患者。随着更多生物製药上市，它们为难治性痤疮提供了新的治疗选择，并有望改变痤疮的治疗方式。
非专利口服痤疮药物的成长：学名药（例如抗生素和类视色素）的上市降低了治疗成本，提高了患者的用药便利性。非专利维A酸和多西环素的上市使这些药物更加经济实惠，尤其是在新兴市场，促进了全球口服痤疮药物消费量的成长。
非处方口服痤疮药物需求成长：全球对非处方口服痤疮药物的需求正在增长，这主要受患者对自我管理和便利性的需求所驱动。草药补充剂和低剂量抗生素等非处方药物越来越普及，并因其疗效而受到轻度痤疮患者的青睐。随着患者寻求更便利的治疗方法，非处方产品的扩张预计将持续下去。

全球口服痤疮药物市场近期发展，包括FDA核准、荷尔蒙疗法、生物製药、学名药和非处方药上市等，正在显着影响市场格局。这些发展为患者提供了更多治疗选择、更低的价格和更方便的用药途径，从而扩大了市场规模，并为患者提供了更好的痤疮治疗方案。

The future of the global oral acne medicine market looks promising with opportunities in the online sales, and offline sales markets. The global oral acne medicine market is expected to grow with a CAGR of 5.1% from 2025 to 2031. The major drivers for this market are rising demand for effective, accessible acne treatments and increasing online retail. and growing awareness of skincare and acne management among consumers worldwide..

Lucintel forecasts that, within the type category, otc is expected to witness higher growth over the forecast period.
Within the application category, online sales is expected to witness the higher growth.
In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Oral Acne Medicine Market

The oral acne medicine market is undergoing significant transformations due to advances in treatment options, increasing awareness, and changing patient preferences. These trends are reshaping how acne is treated and managed globally, influencing both consumer behavior and the development of innovative therapies. As a result, the market is expected to expand further, driven by these key trends.

Shift Towards Personalized Treatment: Personalized treatment for acne is becoming a dominant trend, with more focus on tailoring medications to the individual's specific skin type, genetic factors, and acne severity. This approach increases treatment efficacy and reduces side effects, improving patient adherence. Advances in genetic and microbiome research are enabling more targeted therapies, leading to more precise and effective oral treatments for acne.
Rise of Combination Therapies: Combination therapies, such as oral antibiotics combined with topical treatments or oral retinoids, are gaining popularity. These multi-pronged approaches offer enhanced efficacy by addressing multiple factors that contribute to acne. This trend is reshaping acne treatment regimens, with physicians increasingly recommending combination therapies to achieve faster and longer-lasting results.
Adoption of Biologics and New Drug Classes: Biologics and newer drug classes are emerging as important treatment options for moderate to severe acne. These include biologics targeting the immune system and hormonal therapies for adult acne. These drugs offer an alternative to traditional antibiotics and retinoids, with fewer side effects and improved outcomes. As these drugs gain approval, they are expected to further diversify the oral acne medicine market.
Increasing Focus on Treatment for Adult Acne: Adult acne is becoming more common, particularly among women. This demographic shift is influencing the development of oral acne medications aimed at addressing hormonal imbalances, which are often the root cause of adult acne. As awareness of adult acne grows, the market for oral medications tailored to adult acne is expanding rapidly, especially in developed countries.
Growing Demand for Over-the-Counter Oral Medications: The rise of OTC oral acne medications is a notable trend, driven by patient preference for accessible and affordable treatments. Non-prescription options, such as OTC antibiotics and herbal supplements, are becoming more popular. This trend reflects a broader shift toward self-medication and the growing confidence of patients in managing their acne with over-the-counter options.

Emerging trends such as personalized treatments, combination therapies, biologics, increased focus on adult acne, and the rise of OTC oral medications are reshaping the global oral acne medicine market. These trends not only enhance treatment efficacy but also cater to the changing needs of patients, ultimately expanding the market and improving acne management.

Recent Developments in the Oral Acne Medicine Market

The oral acne medicine market is undergoing rapid innovation, with significant developments occurring in response to growing demand for effective treatments. These innovations span the approval of new drugs, expanded market access, and advancements in treatment options aimed at improving patient outcomes. These developments are contributing to the market's expansion, especially as more patients seek effective, long-term solutions for acne management.

FDA Approvals of New Oral Acne Medications: The U.S. Food and Drug Administration (FDA) has approved several new oral medications for acne, including newer-generation retinoids and antibiotics. These approvals offer patients more options, especially for severe cases of acne. The introduction of novel formulations, such as fixed-dose combinations, helps improve treatment adherence and efficacy, providing a more streamlined approach to acne management.
Launch of Hormonal Treatments for Adult Acne: Oral hormonal treatments, such as contraceptives and anti-androgens, have become more widely recognized as effective solutions for adult acne, particularly among women. These treatments target the hormonal imbalances that often cause adult acne. Pharmaceutical companies are expanding their portfolios to include these treatments, addressing the growing demand for adult acne management options.
Introduction of Biologics for Severe Acne Cases: Biologics such as monoclonal antibodies targeting acne-related inflammation are emerging as promising treatments for severe and cystic acne. These treatments are particularly beneficial for patients who do not respond to traditional therapies like antibiotics or retinoids. As more biologics enter the market, they are offering an alternative for difficult-to-treat cases, potentially reshaping acne management.
Growth of Generic Oral Acne Medications: The availability of generic versions of oral acne medications, such as antibiotics and retinoids, is driving down costs and improving accessibility for patients. The launch of generic Isotretinoin and doxycycline has made these treatments more affordable, particularly in emerging markets, contributing to an overall increase in oral acne medicine consumption worldwide.
Rise in OTC Oral Acne Treatments: The global demand for over-the-counter (OTC) oral acne medications is increasing, driven by patient desire for self-management and convenience. OTC options, such as herbal supplements and low-dose antibiotics, are becoming widely available and are increasingly popular for mild acne cases. This expansion of OTC offerings is expected to continue as patients seek more accessible treatment options.

Recent developments in the global oral acne medicine market, including FDA approvals, the launch of hormonal treatments, biologics, generic options, and OTC products, are significantly shaping the market. These developments offer patients more treatment choices, improve affordability, and enhance access, thereby expanding the market and providing better options for acne management.

Strategic Growth Opportunities in the Oral Acne Medicine Market

The global oral acne medicine market presents several growth opportunities driven by emerging market demands, new treatment innovations, and evolving patient needs. By focusing on key applications such as biologics, combination therapies, and the rise of adult acne treatments, pharmaceutical companies can strategically expand their market share and meet the growing demand for effective acne solutions.

Expansion in Biologics for Severe Acne: The development and commercialization of biologics, particularly monoclonal antibodies, for severe acne represent a significant growth opportunity. These medications target inflammation pathways, offering a solution for patients who do not respond to traditional treatments. With an increasing number of biologics entering clinical trials and gaining approval, the market for these treatments is expected to grow substantially.
Focus on Combination Therapies: The growing trend toward combination therapies-combining oral antibiotics or retinoids with topical treatments-is another key growth opportunity. This approach offers enhanced efficacy by addressing various acne-causing factors, such as bacteria, sebum production, and inflammation. Companies that develop new combination products can tap into a growing market, particularly for patients with moderate to severe acne.
Development of Hormonal Acne Treatments for Adults: With increasing awareness of adult acne, particularly among women, there is a significant growth opportunity in oral hormonal treatments. Products that address the hormonal causes of acne, such as oral contraceptives and anti-androgens, are gaining popularity. Expanding this category can help pharmaceutical companies cater to a new patient demographic, especially in regions with aging populations.
Generics and Affordable Oral Acne Medications: The growing demand for affordable acne treatments in emerging markets presents a major opportunity for the generic drug industry. The increasing availability of generic versions of popular oral acne medications, such as Isotretinoin and doxycycline, can drive market growth by making treatments more accessible to price-sensitive consumers in low- and middle-income countries.
Growth in OTC Oral Acne Products: As patients seek more convenient and accessible acne treatments, the OTC market for oral acne medications is expanding. Developing effective and safe OTC options, including herbal supplements and low-dose antibiotics, can help pharmaceutical companies capture market share in the self-care segment. This trend reflects a broader consumer shift toward self-medication.

Strategic growth opportunities in the global oral acne medicine market lie in biologics, combination therapies, hormonal treatments, generics, and OTC products. Companies that focus on these applications can address unmet needs, expand market reach, and meet the growing demand for effective and affordable acne treatments. The market's evolution will continue to offer new avenues for growth and innovation.

Oral Acne Medicine Market Driver and Challenges

The global oral acne medicine market is driven by various technological, economic, and regulatory factors. These drivers fuel market growth, but several challenges, such as high treatment costs and evolving patient needs, also present obstacles. Understanding these drivers and challenges is essential for companies to navigate the market effectively and ensure continued success.

The factors responsible for driving the Oral Acne Medicine market include:

1. Technological Advancements in Acne Treatment: Innovations in acne treatment, such as the development of biologics and combination therapies, are driving market growth. New drug formulations, including oral retinoids and antibiotics, provide improved efficacy, faster results, and fewer side effects, fueling demand for these treatments globally.

2. Rising Prevalence of Acne Worldwide: The increasing prevalence of acne, especially among teenagers and young adults, is driving the demand for oral acne treatments. The expansion of acne treatments is particularly evident in regions like Asia and Latin America, where rising affluence and urbanization have contributed to higher incidences of acne.

3. Increased Patient Awareness of Acne Treatment Options: Growing awareness about the availability of effective acne treatments is encouraging more patients to seek medical care. Social media, online platforms, and dermatology outreach are driving this awareness, prompting patients to explore both prescription and OTC oral acne medications for better results.

4. Regulatory Support for New Acne Medications: Regulatory bodies like the FDA and EMA are fast-tracking approvals for new acne treatments, especially biologics and hormonal therapies. This regulatory support accelerates market growth by increasing the availability of new treatments, offering patients more options for managing their acne.

5. High Demand for Oral Acne Medications in Emerging Markets: As developing economies grow, the demand for effective oral acne treatments is increasing. Rising disposable incomes, urbanization, and increased focus on skincare are key factors driving market expansion in countries like China, India, and Brazil.

Challenges in the Oral Acne Medicine market are:

1. High Treatment Costs: Despite the growth in oral acne medications, the high cost of treatment, especially for newer drugs and biologics, remains a major challenge. The affordability of treatments in emerging markets is a significant barrier to access, limiting patient uptake.

2. Side Effects and Safety Concerns: Oral acne medications, particularly retinoids and antibiotics, are associated with side effects like dryness, sensitivity, and long-term complications. These concerns can hinder patient adherence and affect treatment outcomes, requiring pharmaceutical companies to address these issues in product development.

3. Competition from OTC Products: The growing availability of OTC oral acne treatments and self-care products is a challenge for prescription oral medications. Patients are increasingly opting for OTC options, which can undermine the demand for prescription-based acne treatments.

Drivers such as technological advancements, increasing acne prevalence, and growing patient awareness are propelling the oral acne medicine market. However, challenges like high treatment costs, side effects, and competition from OTC products need to be addressed for sustained growth. Navigating these factors will be crucial for companies in the oral acne treatment space.

List of Oral Acne Medicine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies oral acne medicine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the oral acne medicine companies profiled in this report include-

Sun Pharma
Mayne Pharma
Lion
Chongqing Huapont
Sine Pharma

Oral Acne Medicine Market by Segment

The study includes a forecast for the global oral acne medicine market by type, application, and region.

Oral Acne Medicine Market by Type [Value from 2019 to 2031]:

Otc
Prescription Medicine

Oral Acne Medicine Market by Application [Value from 2019 to 2031]:

Online Sales
Offline Sales

Oral Acne Medicine Market by Region [Value from 2019 to 2031]:

North America
Europe
Asia Pacific
The Rest of the World

Country Wise Outlook for the Oral Acne Medicine Market

The global oral acne medicine market is evolving rapidly as advancements in pharmaceutical research, regulatory approvals, and the growing awareness about acne treatment drive demand. Oral acne medications, including antibiotics, retinoids, and newer biologics, continue to gain popularity. Regions like the United States, China, Germany, India, and Japan are witnessing significant developments in the market, driven by increasing awareness of acne's impact and the rising prevalence of skin conditions across diverse populations.

United States: The U.S. market for oral acne treatments has seen significant growth, driven by increasing awareness and access to advanced medications like oral retinoids and antibiotics. The FDA's approval of new oral treatments, such as oral clindamycin and Isotretinoin, has led to improved patient outcomes. There is also rising demand for combination therapies, with many patients opting for holistic acne management through oral medications alongside topical treatments.
China: In China, the oral acne medicine market is expanding due to the growing number of adolescents and young adults seeking treatment for acne. The country's rising affluence and focus on skincare have led to increased demand for oral medications. Recent regulatory changes have also made it easier for pharmaceutical companies to bring new acne treatments to market, allowing for quicker access to oral antibiotics and retinoids for acne patients.
Germany: Germany's oral acne medicine market is experiencing growth driven by an increasing focus on dermatology and the rising prevalence of acne among both teenagers and adults. Oral medications like Isotretinoin and antibiotics are commonly prescribed, with a growing preference for oral isotretinoin in cases of severe acne. Additionally, Germany's healthcare system offers extensive insurance coverage for acne treatments, making access to oral acne medication more affordable for patients.
India: In India, the oral acne medicine market is evolving as the increasing prevalence of acne among teenagers and young adults drives demand for effective treatments. There is a growing preference for affordable oral medications, including antibiotics like doxycycline, and retinoids. Additionally, the availability of generics has significantly reduced the cost of treatment, making oral acne therapies accessible to a larger segment of the population in India.
Japan: Japan's oral acne treatment market is also growing, with an increasing focus on effective acne management. Oral antibiotics, such as tetracycline, and retinoids like Isotretinoin are gaining popularity. Japan's aging population is seeing a rise in adult acne, contributing to the growth in oral acne medication demand. Moreover, the country's well-developed healthcare infrastructure and insurance coverage help improve accessibility to these medications.

Features of the Global Oral Acne Medicine Market

Market Size Estimates: Oral acne medicine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Oral acne medicine market size by type, application, and region in terms of value ($B).
Regional Analysis: Oral acne medicine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the oral acne medicine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the oral acne medicine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the oral acne medicine market by type (otc and prescription medicine), application (online sales and offline sales), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Market Overview

2.1 Background and Classifications
2.2 Supply Chain

3. Market Trends & Forecast Analysis

3.2 Industry Drivers and Challenges
3.3 PESTLE Analysis
3.4 Patent Analysis
3.5 Regulatory Environment

4. Global Oral Acne Medicine Market by Type

4.1 Overview
4.2 Attractiveness Analysis by Type
4.3 OTC: Trends and Forecast (2019-2031)
4.4 Prescription Medicine: Trends and Forecast (2019-2031)

5. Global Oral Acne Medicine Market by Application

5.1 Overview
5.2 Attractiveness Analysis by Application
5.3 Online Sales: Trends and Forecast (2019-2031)
5.4 Offline Sales: Trends and Forecast (2019-2031)

6. Regional Analysis

6.1 Overview
6.2 Global Oral Acne Medicine Market by Region

7. North American Oral Acne Medicine Market

7.1 Overview
7.2 North American Oral Acne Medicine Market by type
7.3 North American Oral Acne Medicine Market by application
7.4 United States Oral Acne Medicine Market
7.5 Mexican Oral Acne Medicine Market
7.6 Canadian Oral Acne Medicine Market

8. European Oral Acne Medicine Market

8.1 Overview
8.2 European Oral Acne Medicine Market by type
8.3 European Oral Acne Medicine Market by application
8.4 German Oral Acne Medicine Market
8.5 French Oral Acne Medicine Market
8.6 Spanish Oral Acne Medicine Market
8.7 Italian Oral Acne Medicine Market
8.8 United Kingdom Oral Acne Medicine Market

9. APAC Oral Acne Medicine Market

9.1 Overview
9.2 APAC Oral Acne Medicine Market by type
9.3 APAC Oral Acne Medicine Market by application
9.4 Japanese Oral Acne Medicine Market
9.5 Indian Oral Acne Medicine Market
9.6 Chinese Oral Acne Medicine Market
9.7 South Korean Oral Acne Medicine Market
9.8 Indonesian Oral Acne Medicine Market

10. ROW Oral Acne Medicine Market

10.1 Overview
10.2 ROW Oral Acne Medicine Market by type
10.3 ROW Oral Acne Medicine Market by application
10.4 Middle Eastern Oral Acne Medicine Market
10.5 South American Oral Acne Medicine Market
10.6 African Oral Acne Medicine Market

11. Competitor Analysis

11.1 Product Portfolio Analysis
11.2 Operational Integration
11.3 Porter's Five Forces Analysis
- Competitive Rivalry
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Threat of Substitutes
- Threat of New Entrants
11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

12.1 Value Chain Analysis
12.2 Growth Opportunity Analysis
- 12.2.1 Growth Opportunities by Type
- 12.2.2 Growth Opportunities by Application
12.3 Emerging Trends in the Global Oral Acne Medicine Market
12.4 Strategic Analysis
- 12.4.1 New Product Development
- 12.4.2 Certification and Licensing
- 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

13.1 Competitive Analysis
13.2 Sun Pharma
- Company Overview
- Oral Acne Medicine Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.3 Mayne Pharma
- Company Overview
- Oral Acne Medicine Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.4 Lion
- Company Overview
- Oral Acne Medicine Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.5 Chongqing Huapont
- Company Overview
- Oral Acne Medicine Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.6 Sine Pharma
- Company Overview
- Oral Acne Medicine Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing

14. Appendix

14.1 List of Figures
14.2 List of Tables
14.3 Research Methodology
14.4 Disclaimer
14.5 Copyright
14.6 Abbreviations and Technical Units
14.7 About Us
14.8 Contact Us

简介目录图表

List of Figures

Figure 1.1: Trends and Forecast for the Global Oral Acne Medicine Market
Figure 2.1: Usage of Oral Acne Medicine Market
Figure 2.2: Classification of the Global Oral Acne Medicine Market
Figure 2.3: Supply Chain of the Global Oral Acne Medicine Market
Figure 3.1: Driver and Challenges of the Oral Acne Medicine Market
Figure 3.2: PESTLE Analysis
Figure 3.3: Patent Analysis
Figure 3.4: Regulatory Environment
Figure 4.1: Global Oral Acne Medicine Market by Type in 2019, 2024, and 2031
Figure 4.2: Trends of the Global Oral Acne Medicine Market ($B) by Type
Figure 4.3: Forecast for the Global Oral Acne Medicine Market ($B) by Type
Figure 4.4: Trends and Forecast for OTC in the Global Oral Acne Medicine Market (2019-2031)
Figure 4.5: Trends and Forecast for Prescription Medicine in the Global Oral Acne Medicine Market (2019-2031)
Figure 5.1: Global Oral Acne Medicine Market by Application in 2019, 2024, and 2031
Figure 5.2: Trends of the Global Oral Acne Medicine Market ($B) by Application
Figure 5.3: Forecast for the Global Oral Acne Medicine Market ($B) by Application
Figure 5.4: Trends and Forecast for Online Sales in the Global Oral Acne Medicine Market (2019-2031)
Figure 5.5: Trends and Forecast for Offline Sales in the Global Oral Acne Medicine Market (2019-2031)
Figure 6.1: Trends of the Global Oral Acne Medicine Market ($B) by Region (2019-2024)
Figure 6.2: Forecast for the Global Oral Acne Medicine Market ($B) by Region (2025-2031)
Figure 7.1: North American Oral Acne Medicine Market by type in 2019, 2024, and 2031
Figure 7.2: Trends of the North American Oral Acne Medicine Market ($B) by type (2019-2024)
Figure 7.3: Forecast for the North American Oral Acne Medicine Market ($B) by type (2025-2031)
Figure 7.4: North American Oral Acne Medicine Market by application in 2019, 2024, and 2031
Figure 7.5: Trends of the North American Oral Acne Medicine Market ($B) by application (2019-2024)
Figure 7.6: Forecast for the North American Oral Acne Medicine Market ($B) by application (2025-2031)
Figure 7.7: Trends and Forecast for the United States Oral Acne Medicine Market ($B) (2019-2031)
Figure 7.8: Trends and Forecast for the Mexican Oral Acne Medicine Market ($B) (2019-2031)
Figure 7.9: Trends and Forecast for the Canadian Oral Acne Medicine Market ($B) (2019-2031)
Figure 8.1: European Oral Acne Medicine Market by type in 2019, 2024, and 2031
Figure 8.2: Trends of the European Oral Acne Medicine Market ($B) by type (2019-2024)
Figure 8.3: Forecast for the European Oral Acne Medicine Market ($B) by type (2025-2031)
Figure 8.4: European Oral Acne Medicine Market by application in 2019, 2024, and 2031
Figure 8.5: Trends of the European Oral Acne Medicine Market ($B) by application (2019-2024)
Figure 8.6: Forecast for the European Oral Acne Medicine Market ($B) by application (2025-2031)
Figure 8.7: Trends and Forecast for the German Oral Acne Medicine Market ($B) (2019-2031)
Figure 8.8: Trends and Forecast for the French Oral Acne Medicine Market ($B) (2019-2031)
Figure 8.9: Trends and Forecast for the Spanish Oral Acne Medicine Market ($B) (2019-2031)
Figure 8.10: Trends and Forecast for the Italian Oral Acne Medicine Market ($B) (2019-2031)
Figure 8.11: Trends and Forecast for the United Kingdom Oral Acne Medicine Market ($B) (2019-2031)
Figure 9.1: APAC Oral Acne Medicine Market by type in 2019, 2024, and 2031
Figure 9.2: Trends of the APAC Oral Acne Medicine Market ($B) by type (2019-2024)
Figure 9.3: Forecast for the APAC Oral Acne Medicine Market ($B) by type (2025-2031)
Figure 9.4: APAC Oral Acne Medicine Market by application in 2019, 2024, and 2031
Figure 9.5: Trends of the APAC Oral Acne Medicine Market ($B) by application (2019-2024)
Figure 9.6: Forecast for the APAC Oral Acne Medicine Market ($B) by application (2025-2031)
Figure 9.7: Trends and Forecast for the Japanese Oral Acne Medicine Market ($B) (2019-2031)
Figure 9.8: Trends and Forecast for the Indian Oral Acne Medicine Market ($B) (2019-2031)
Figure 9.9: Trends and Forecast for the Chinese Oral Acne Medicine Market ($B) (2019-2031)
Figure 9.10: Trends and Forecast for the South Korean Oral Acne Medicine Market ($B) (2019-2031)
Figure 9.11: Trends and Forecast for the Indonesian Oral Acne Medicine Market ($B) (2019-2031)
Figure 10.1: ROW Oral Acne Medicine Market by type in 2019, 2024, and 2031
Figure 10.2: Trends of the ROW Oral Acne Medicine Market ($B) by type (2019-2024)
Figure 10.3: Forecast for the ROW Oral Acne Medicine Market ($B) by type (2025-2031)
Figure 10.4: ROW Oral Acne Medicine Market by application in 2019, 2024, and 2031
Figure 10.5: Trends of the ROW Oral Acne Medicine Market ($B) by application (2019-2024)
Figure 10.6: Forecast for the ROW Oral Acne Medicine Market ($B) by application (2025-2031)
Figure 10.7: Trends and Forecast for the Middle Eastern Oral Acne Medicine Market ($B) (2019-2031)
Figure 10.8: Trends and Forecast for the South American Oral Acne Medicine Market ($B) (2019-2031)
Figure 10.9: Trends and Forecast for the African Oral Acne Medicine Market ($B) (2019-2031)
Figure 11.1: Porter's Five Forces Analysis of the Global Oral Acne Medicine Market
Figure 11.2: Market Share (%) of Top Players in the Global Oral Acne Medicine Market (2024)
Figure 12.1: Growth Opportunities for the Global Oral Acne Medicine Market by Type
Figure 12.2: Growth Opportunities for the Global Oral Acne Medicine Market by Application
Figure 12.3: Growth Opportunities for the Global Oral Acne Medicine Market by Region
Figure 12.4: Emerging Trends in the Global Oral Acne Medicine Market

List of Tables

Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Oral Acne Medicine Market by Type and Application
Table 1.2: Attractiveness Analysis for the Oral Acne Medicine Market by Region
Table 1.3: Global Oral Acne Medicine Market Parameters and Attributes
Table 3.1: Trends of the Global Oral Acne Medicine Market (2019-2024)
Table 3.2: Forecast for the Global Oral Acne Medicine Market (2025-2031)
Table 4.1: Attractiveness Analysis for the Global Oral Acne Medicine Market by Type
Table 4.2: Market Size and CAGR of Various Type in the Global Oral Acne Medicine Market (2019-2024)
Table 4.3: Market Size and CAGR of Various Type in the Global Oral Acne Medicine Market (2025-2031)
Table 4.4: Trends of OTC in the Global Oral Acne Medicine Market (2019-2024)
Table 4.5: Forecast for OTC in the Global Oral Acne Medicine Market (2025-2031)
Table 4.6: Trends of Prescription Medicine in the Global Oral Acne Medicine Market (2019-2024)
Table 4.7: Forecast for Prescription Medicine in the Global Oral Acne Medicine Market (2025-2031)
Table 5.1: Attractiveness Analysis for the Global Oral Acne Medicine Market by Application
Table 5.2: Market Size and CAGR of Various Application in the Global Oral Acne Medicine Market (2019-2024)
Table 5.3: Market Size and CAGR of Various Application in the Global Oral Acne Medicine Market (2025-2031)
Table 5.4: Trends of Online Sales in the Global Oral Acne Medicine Market (2019-2024)
Table 5.5: Forecast for Online Sales in the Global Oral Acne Medicine Market (2025-2031)
Table 5.6: Trends of Offline Sales in the Global Oral Acne Medicine Market (2019-2024)
Table 5.7: Forecast for Offline Sales in the Global Oral Acne Medicine Market (2025-2031)
Table 6.1: Market Size and CAGR of Various Regions in the Global Oral Acne Medicine Market (2019-2024)
Table 6.2: Market Size and CAGR of Various Regions in the Global Oral Acne Medicine Market (2025-2031)
Table 7.1: Trends of the North American Oral Acne Medicine Market (2019-2024)
Table 7.2: Forecast for the North American Oral Acne Medicine Market (2025-2031)
Table 7.3: Market Size and CAGR of Various type in the North American Oral Acne Medicine Market (2019-2024)
Table 7.4: Market Size and CAGR of Various type in the North American Oral Acne Medicine Market (2025-2031)
Table 7.5: Market Size and CAGR of Various application in the North American Oral Acne Medicine Market (2019-2024)
Table 7.6: Market Size and CAGR of Various application in the North American Oral Acne Medicine Market (2025-2031)
Table 7.7: Trends and Forecast for the United States Oral Acne Medicine Market (2019-2031)
Table 7.8: Trends and Forecast for the Mexican Oral Acne Medicine Market (2019-2031)
Table 7.9: Trends and Forecast for the Canadian Oral Acne Medicine Market (2019-2031)
Table 8.1: Trends of the European Oral Acne Medicine Market (2019-2024)
Table 8.2: Forecast for the European Oral Acne Medicine Market (2025-2031)
Table 8.3: Market Size and CAGR of Various type in the European Oral Acne Medicine Market (2019-2024)
Table 8.4: Market Size and CAGR of Various type in the European Oral Acne Medicine Market (2025-2031)
Table 8.5: Market Size and CAGR of Various application in the European Oral Acne Medicine Market (2019-2024)
Table 8.6: Market Size and CAGR of Various application in the European Oral Acne Medicine Market (2025-2031)
Table 8.7: Trends and Forecast for the German Oral Acne Medicine Market (2019-2031)
Table 8.8: Trends and Forecast for the French Oral Acne Medicine Market (2019-2031)
Table 8.9: Trends and Forecast for the Spanish Oral Acne Medicine Market (2019-2031)
Table 8.10: Trends and Forecast for the Italian Oral Acne Medicine Market (2019-2031)
Table 8.11: Trends and Forecast for the United Kingdom Oral Acne Medicine Market (2019-2031)
Table 9.1: Trends of the APAC Oral Acne Medicine Market (2019-2024)
Table 9.2: Forecast for the APAC Oral Acne Medicine Market (2025-2031)
Table 9.3: Market Size and CAGR of Various type in the APAC Oral Acne Medicine Market (2019-2024)
Table 9.4: Market Size and CAGR of Various type in the APAC Oral Acne Medicine Market (2025-2031)
Table 9.5: Market Size and CAGR of Various application in the APAC Oral Acne Medicine Market (2019-2024)
Table 9.6: Market Size and CAGR of Various application in the APAC Oral Acne Medicine Market (2025-2031)
Table 9.7: Trends and Forecast for the Japanese Oral Acne Medicine Market (2019-2031)
Table 9.8: Trends and Forecast for the Indian Oral Acne Medicine Market (2019-2031)
Table 9.9: Trends and Forecast for the Chinese Oral Acne Medicine Market (2019-2031)
Table 9.10: Trends and Forecast for the South Korean Oral Acne Medicine Market (2019-2031)
Table 9.11: Trends and Forecast for the Indonesian Oral Acne Medicine Market (2019-2031)
Table 10.1: Trends of the ROW Oral Acne Medicine Market (2019-2024)
Table 10.2: Forecast for the ROW Oral Acne Medicine Market (2025-2031)
Table 10.3: Market Size and CAGR of Various type in the ROW Oral Acne Medicine Market (2019-2024)
Table 10.4: Market Size and CAGR of Various type in the ROW Oral Acne Medicine Market (2025-2031)
Table 10.5: Market Size and CAGR of Various application in the ROW Oral Acne Medicine Market (2019-2024)
Table 10.6: Market Size and CAGR of Various application in the ROW Oral Acne Medicine Market (2025-2031)
Table 10.7: Trends and Forecast for the Middle Eastern Oral Acne Medicine Market (2019-2031)
Table 10.8: Trends and Forecast for the South American Oral Acne Medicine Market (2019-2031)
Table 10.9: Trends and Forecast for the African Oral Acne Medicine Market (2019-2031)
Table 11.1: Product Mapping of Oral Acne Medicine Suppliers Based on Segments
Table 11.2: Operational Integration of Oral Acne Medicine Manufacturers
Table 11.3: Rankings of Suppliers Based on Oral Acne Medicine Revenue
Table 12.1: New Product Launches by Major Oral Acne Medicine Producers (2019-2024)
Table 12.2: Certification Acquired by Major Competitor in the Global Oral Acne Medicine Market

02-2729-4219

+886-2-2729-4219

License/价格

口服痤疮治疗市场报告：趋势、预测和竞争分析（至2031年）

Oral Acne Medicine Market Report: Trends, Forecast and Competitive Analysis to 2031

目录

第一章执行摘要

第二章市场概览

第三章：市场趋势与预测分析

第四章全球口服痤疮治疗市场（按类型划分）

5. 全球口服痤疮治疗市场（按应用划分）

第六章区域分析

7. 北美口服痤疮治疗市场

8. 欧洲口服痤疮治疗市场

9. 亚太地区口服痤疮治疗市场

10. 世界其他地区（ROW）口服痤疮治疗市场

第十一章竞争分析

第十二章：机会与策略分析